André Mansinho

988 total citations
36 papers, 400 citations indexed

About

André Mansinho is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, André Mansinho has authored 36 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in André Mansinho's work include Radiopharmaceutical Chemistry and Applications (8 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Bone health and treatments (7 papers). André Mansinho is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (8 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Bone health and treatments (7 papers). André Mansinho collaborates with scholars based in Portugal, United States and United Kingdom. André Mansinho's co-authors include Luís Costa, Sandra Casimiro, Daniela Macedo, Isabel Fernandes, Irina Alho, Arlindo R. Ferreira, Valentina Boni, Maria J. de Miguel, Emiliano Calvo and Ricardo M. Fernandes and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and International Journal of Molecular Sciences.

In The Last Decade

André Mansinho

32 papers receiving 397 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
André Mansinho Portugal 11 220 149 109 101 50 36 400
Xinhai Wan United States 9 208 0.9× 235 1.6× 185 1.7× 119 1.2× 26 0.5× 10 503
Karel Cwiertka Czechia 10 247 1.1× 115 0.8× 123 1.1× 108 1.1× 40 0.8× 45 436
Jelena Urosevic Spain 8 227 1.0× 221 1.5× 72 0.7× 111 1.1× 28 0.6× 10 462
Luis Manuel Martínez-Barrera Mexico 10 271 1.2× 158 1.1× 270 2.5× 72 0.7× 42 0.8× 23 524
Faith Nutter United Kingdom 9 231 1.1× 157 1.1× 82 0.8× 63 0.6× 89 1.8× 12 466
Yunchao Huang China 13 179 0.8× 157 1.1× 167 1.5× 130 1.3× 65 1.3× 30 475
Xinjian Huang China 13 172 0.8× 190 1.3× 68 0.6× 112 1.1× 34 0.7× 25 395
Yunfu Deng China 12 219 1.0× 108 0.7× 105 1.0× 118 1.2× 68 1.4× 20 402
Thomas G. Johnson Australia 6 152 0.7× 151 1.0× 121 1.1× 103 1.0× 23 0.5× 9 484
Coralie Moncharmont France 9 204 0.9× 157 1.1× 160 1.5× 83 0.8× 59 1.2× 26 437

Countries citing papers authored by André Mansinho

Since Specialization
Citations

This map shows the geographic impact of André Mansinho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by André Mansinho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites André Mansinho more than expected).

Fields of papers citing papers by André Mansinho

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by André Mansinho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by André Mansinho. The network helps show where André Mansinho may publish in the future.

Co-authorship network of co-authors of André Mansinho

This figure shows the co-authorship network connecting the top 25 collaborators of André Mansinho. A scholar is included among the top collaborators of André Mansinho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with André Mansinho. André Mansinho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Menezes, Maria, et al.. (2024). Retro TIMing: A multicentric retrospective analysis of immunotherapy timing in metastatic melanoma.. Journal of Clinical Oncology. 42(16_suppl). 9542–9542. 2 indexed citations
2.
Voss, Martin H., Benjamin Garmezy, J.P. Maroto Rey, et al.. (2023). 1883MO MEDI5752 (volrustomig), a novel PD-1/CTLA-4 bispecific antibody, in the first-line (1L) treatment of 65 patients (pts) with advanced clear cell renal cell carcinoma (aRCC). Annals of Oncology. 34. S1012–S1012. 7 indexed citations
3.
Mansinho, André, et al.. (2023). Avelumab as First-Line Maintenance Treatment in Locally Advanced or Metastatic Urothelial Carcinoma. Advances in Therapy. 40(10). 4134–4150. 5 indexed citations
4.
Pérez, Vanessa, et al.. (2023). Immunotherapy around the Clock: Impact of Infusion Timing on Stage IV Melanoma Outcomes. Cells. 12(16). 2068–2068. 17 indexed citations
5.
Gallego-Paez, Lina M., María Jiménez, Patricia G. Santamarı́a, et al.. (2023). Co-targeting RANK pathway treats and prevents acquired resistance to CDK4/6 inhibitors in luminal breast cancer. Cell Reports Medicine. 4(8). 101120–101120. 7 indexed citations
6.
Costa, Luís, André Mansinho, Cláudia Vieira, et al.. (2023). Health outcomes and budget impact projection of anti-PD-(L)1s in cancer care in Portugal. Frontiers in Public Health. 11. 1133959–1133959. 2 indexed citations
7.
Mansinho, André, Ricardo M. Fernandes, & António Vaz Carneiro. (2022). Histology-Agnostic Drugs: A Paradigm Shift—A Narrative Review. Advances in Therapy. 40(4). 1379–1392. 11 indexed citations
8.
Soares‐de‐Almeida, Luís, et al.. (2021). BRAF L597K mutation: an opportunity to treat. Dermatology Online Journal. 27(1). 2 indexed citations
9.
Mansinho, André, et al.. (2021). Management of bone metastases in renal cell carcinoma: bone-targeted treatments, systemic therapies, and radiotherapy. Journal of Cancer Metastasis and Treatment.
12.
Ferreira, Arlindo R., André Mansinho, Sandra Casimiro, et al.. (2020). Impact of Extraskeletal Metastases on Skeletal-Related Events in Metastatic Castration-Resistant Prostate Cancer with Bone Metastases. Cancers. 12(8). 2034–2034. 6 indexed citations
13.
Mansinho, André, Valentina Boni, Maria J. de Miguel, & Emiliano Calvo. (2019). New designs in early clinical drug development. Annals of Oncology. 30(9). 1460–1465. 13 indexed citations
14.
Martins, Marta, et al.. (2018). Anti-EGFR Therapy to Treat Metastatic Colorectal Cancer: Not for All. Advances in experimental medicine and biology. 1110. 113–131. 18 indexed citations
15.
Mansinho, André, Daniela Macedo, Isabel Fernandes, & Luís Costa. (2018). Castration-Resistant Prostate Cancer: Mechanisms, Targets and Treatment. Advances in experimental medicine and biology. 1096. 117–133. 86 indexed citations
16.
Ferreira, Arlindo R., Irina Alho, André Mansinho, et al.. (2017). Serum YB-1 (Y-box binding protein 1) as a biomarker of bone disease progression in patients with breast cancer and bone metastases. Journal of bone oncology. 6. 16–21. 22 indexed citations
17.
Ferreira, Arlindo R., et al.. (2017). Bone metastasis risk factors in breast cancer. ecancermedicalscience. 11. 715–715. 75 indexed citations
18.
Mansinho, André, et al.. (2015). ABORDAGEM TERAPÊUTICA DO SARCOMA DE KAPOSI – A IMPORTÂNCIA DA MULTIDISCIPLINARIDADE. SHILAP Revista de lepidopterología. 73(2). 199–208. 2 indexed citations
19.
Mansinho, André, et al.. (2015). MANAGEMENT AND TREATMENT OF KAPOSI’S SARCOMA – THE IMPORTANCE OF THE MULTIDISCIPLINARY. Journal of the Portuguese Society of Dermatology and Venereology. 73(2). 199–208. 1 indexed citations
20.
Fernandes, Isabel, et al.. (2015). Impact of the economic crisis in the approval of new oncological drugs:the Portuguese paradigm. Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT). 1(9). 15–18. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026